109 related articles for article (PubMed ID: 21503556)
1. Procurement of generic medicines in a medium size municipality.
Bevilacqua G; Farias MR; Blatt CR
Rev Saude Publica; 2011 Jun; 45(3):583-9. PubMed ID: 21503556
[TBL] [Abstract][Full Text] [Related]
2. Inflated medicine prices in Vietnam: a qualitative study.
Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
Health Policy Plan; 2017 Jun; 32(5):647-656. PubMed ID: 28453716
[TBL] [Abstract][Full Text] [Related]
3. Municipal consortia for medicine procurement: impact on the stock-out and budget.
Amaral SM; Blatt CR
Rev Saude Publica; 2011 Aug; 45(4):799-801. PubMed ID: 21445459
[TBL] [Abstract][Full Text] [Related]
4. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.
Flood D; Mathieu I; Chary A; García P; Rohloff P
BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866
[TBL] [Abstract][Full Text] [Related]
5. Investment of financial resources for the procurement of medicines for primary care in Brazilian municipalities.
Pontes MA; Tavares NUL; Francisco PMSB; Naves JOS
Cien Saude Colet; 2017 Aug; 22(8):2453-2462. PubMed ID: 28793063
[TBL] [Abstract][Full Text] [Related]
6. The crisis in access to essential medicines in India: key issues which call for action.
Bhargava A; Kalantri SP
Indian J Med Ethics; 2013; 10(2):86-95. PubMed ID: 23697486
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical services in Rio de Janeiro Municipality, Brazil: development regarding selected aspects from 2008 to 2014.
Silva RM; Pereira NC; Mendes LV; Luiza VL
Cien Saude Colet; 2016 May; 21(5):1421-32. PubMed ID: 27166892
[TBL] [Abstract][Full Text] [Related]
8. Demand-side policies to encourage the use of generic medicines: an overview.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447
[TBL] [Abstract][Full Text] [Related]
9. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
Chua GN; Hassali MA; Shafie AA; Awaisu A
Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
[TBL] [Abstract][Full Text] [Related]
10. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
[TBL] [Abstract][Full Text] [Related]
11. Retailing policies for generic medicines.
Narciso S
Int J Health Care Finance Econ; 2005 Jun; 5(2):165-90. PubMed ID: 15912315
[TBL] [Abstract][Full Text] [Related]
12. Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis.
Liu J; Wang L; Liu C; Zhang X
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):625-631. PubMed ID: 28503962
[TBL] [Abstract][Full Text] [Related]
13. Judicialization of medicines: effectiveness of rights or break in public policies?
Oliveira YMDC; Braga BSF; Farias AD; Pereira SPD; Ferreira MAF
Rev Saude Publica; 2020; 54():130. PubMed ID: 33331524
[TBL] [Abstract][Full Text] [Related]
14. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
15. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?
Cameron A; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
Value Health; 2012; 15(5):664-73. PubMed ID: 22867775
[TBL] [Abstract][Full Text] [Related]
16. Pricing and components analysis of some key essential pediatric medicine in Odisha state.
Samal S; Swain TR
Indian J Pharmacol; 2017; 49(1):89-92. PubMed ID: 28458429
[TBL] [Abstract][Full Text] [Related]
17. Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products.
García-Arieta A; Morales-Alcelay S; Herranz M; de la Torre-Alvarado JM; Blázquez-Pérez A; Suárez-Gea ML; Alvarez C
Int J Pharm; 2012 Feb; 423(2):321-5. PubMed ID: 22120644
[TBL] [Abstract][Full Text] [Related]
18. [Price differences between generic and innovator medicines in Brazil].
Vieira FS; Zucchi P
Rev Saude Publica; 2006 Jun; 40(3):444-9. PubMed ID: 16810368
[TBL] [Abstract][Full Text] [Related]
19. [Bioequivalence studies of pharmaceutical preparations].
Vetchý D; Frýbortová K; Rabisková M; Danecková H
Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
[TBL] [Abstract][Full Text] [Related]
20. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
